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Abstract
Background:  Asthma and allergic diseases are becoming increasingly frequent in children in urban
centres of Latin America although the prevalence of allergic disease is still low in rural areas. Understanding
better why the prevalence of asthma is greater in urban migrant populations and the role of risk factors
such as life style and environmental exposures, may be key to understand what is behind this trend.
Methods/design: The Esmeraldas-SCAALA (Social Changes, Asthma and Allergy in Latin America) study
consists of cross-sectional and nested case-control studies of school children in rural and urban areas of
Esmeraldas Province in Ecuador. The cross-sectional study will investigate risk factors for atopy and
allergic disease in rural and migrant urban Afro-Ecuadorian school children and the nested case-control
study will examine environmental, biologic and social risk factors for asthma among asthma cases and non-
asthmatic controls from the cross-sectional study. Data will be collected through standardised
questionnaires, skin prick testing to relevant aeroallergen extracts, stool examinations for parasites, blood
sampling (for measurement of IgE, interleukins and other immunological parameters), anthropometric
measurements for assessment of nutritional status, exercise testing for assessment of exercise-induced
bronchospasm and dust sampling for measurement of household endotoxin and allergen levels.
Discussion: The information will be used to identify the factors associated with an increased risk of
asthma and allergies in migrant and urbanizing populations, to improve the understanding of the causes of
the increase in asthma prevalence and to identify potentially modifiable factors to inform the design of
prevention programmes to reduce the risk of allergy in urban populations in Latin America.
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Background
Large increases in the prevalence of asthma and allergic
diseases have been reported in industrialized countries
during the last twenty to thirty years [1,2], although there
is evidence that the observed increase in asthma has
reached a plateau in some industrialized countries [3,4].
There is strong evidence for differences in the prevalence
of allergic diseases between urban and rural areas in
Europe and in non-industrialized countries, with higher
prevalences of allergic diseases reported in urban areas [5-
7].
Allergic diseases are caused by a complex interaction
between host genetics and environmental exposures.
Temporal trends in allergy prevalence in developed coun-
tries [4], and the differences in allergy risk between urban
and rural populations of the same ethnicity in developing
countries [8], indicate that changes in environmental
exposure rather than genetic factors are the most likely
explanation for these epidemiological observations.
Rural residence is consistently identified as the strongest
protective factor against asthma in epidemiological stud-
ies [7,9] and is likely to be associated with environmental
exposures such as life style, diet, and hygiene [3,4,10].
Numerous epidemiological studies have provided evi-
dence that migration from countries of low asthma prev-
alence (non-industrialized countries) to those of high
asthma prevalence (industrialized countries) is associated
with an increased risk of allergic disease [11-14], but the
environmental factors that determine this have not been
identified. There are few published studies of allergic dis-
eases among migrant populations within non-industrial-
ized countries [8] that migrate from low-risk rural areas to
high-risk urban areas.
Changes in exposures to many different environmental
and life style factors are likely to occur in populations that
migrate from rural to urban areas, and studies of migrants
to urban areas and comparisons of environmental expo-
sures with the original rural and with more established
urban populations should allow the effects of environ-
mental exposures in early life (e.g. causing immune pro-
gramming) on allergy risk to be distinguished from the
effects of current exposures. Clarification of the dynamics
behind the causation of allergy and asthma in urban
migrant populations will further improve our under-
standing of what is behind the increase of frequency of
these diseases with urbanization and westernization. The
identification of modifiable risk factors could lead to new
public health initiatives to reduce the burden of allergic
disease among urbanizing populations.
Latin American countries are undergoing a rapid process
of population change that includes urbanization, migra-
tion, economic development and adoption of a "modern"
lifestyle. Among the burgeoning urban populations of
Ecuador and other Latin American countries, asthma and
allergic diseases are perceived to be an increasingly impor-
tant public health problem of children [15], although
there is limited data quantifying the magnitude of the
problem and the associated risk factors. The International
Study of Asthma and Allergies in Childhood (ISAAC)
compared the prevalence of allergic disease in school-age
children using a standardized questionnaire and found
that urban centres in Latin America have among the high-
est rates of allergic symptoms worldwide [16]. School
children living in rural areas of Ecuador appear to have
very low risks of allergic disease [17]. Current trends of
continuing rural-urban migration, coupled with the large
expected increases in the urban population of Ecuador
over the next 10 years, make it likely that allergic diseases,
including asthma, will become a significant public health
problem in the future.
The study described here is part of the Programme "Social
Change, Asthma and Allergy in Latin America" (SCAALA),
a research programme being conducted in Ecuador and
Brazil (in the North Eastern city of Salvador), funded by
The Wellcome Trust as part of the programme of Major
Awards to Centres of Excellence in Latin America. The
SCAALA collaboration aims to clarify the social and bio-
logical mechanisms that mediate the effect of population
and lifestyle changes on the frequency of atopic diseases.
This paper deals with the methodological aspects of the
study being conducted in Ecuador.
The study in Ecuador aims to study changes in the preva-
lence and risk factors for asthma and allergy in popula-
tions that migrate from rural to urban areas and examine
how such changes may relate to changes in the risk of
atopic disease. The study will measure the frequency of
symptoms of asthma, allergic rhinitis and atopic dermati-
tis in school children in urban and rural areas, and will
collect detailed information on life style factors and envi-
ronmental exposures that may affect the frequency of
atopic diseases in the urban and rural environments. The
study will investigate also changes in key immunologic
factors (i.e. cytokines) and environmental exposures (i.e.
exposure to aeroallergens in the household) that may be
associated with altered asthma risk in the rural and urban
study groups. On the other hand, the SCAALA study in
Brazil aims to investigate the associations between the
prevalence and incidence of allergic diseases, environ-
mental exposures, particularly hygiene-related exposures,
and immunological parameters in a cohort of children in
the city of Salvador in the State of Bahia, and has been
described elsewhere [18].BMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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Methods/design
Ecuador is among the poorest of South American coun-
tries, with an estimated per capita GDP of US$4,300 in
2005 and industrialization that is far less advanced com-
pared to richer countries in the region, such as Chile (GDP
per capita, US$11,300 and Argentina (GDP per capita,
US$13,100) [19]. In Ecuador, the process of industrial
development accelerated from the 1970s as a conse-
quence of revenues available from oil exploitation in the
Eastern forest region. Industrial development has been
associated with a high rate of population growth in the cit-
ies, estimated to be 2.5% annually in 2000 [20]. There
have been large increases in the urban proportion of Ecua-
dor's population that rose from 42% to 65% during the
period 1975 to 2000 and is projected to reach 76% by
2015 [20]. The new urban centres are home to 50% of the
country's poor [20].
Study site
The study is based in Ecuador's northern coastal province,
Esmeraldas Province. The Province covers an area of
15,237 km2  and has a population of approximately
429,000. The main economic activities are oil industry,
tourism, timber extraction, and African palm oil. The
principal city in the Province is Esmeraldas, with a popu-
lation of 250,566 that is home to approximately 80% of
the Ecuador's Afro-Ecuadorian population [21]. Esmeral-
das Province is one of the poorest regions of Ecuador, with
a per capita income that is less than half the national aver-
age. An estimated 70% of the economically active popula-
tion in the city of Esmeraldas is unemployed or under-
employed, and 60% have no access to basic services such
as electricity, drinking water and sanitation [21]. Over the
past 30 years there have been large migrations of Afro-
Ecuadorians from rural areas of the Province to the city of
Esmeraldas, largely as a consequence of displacement by
African palm oil plantations and by migrants from other
Provinces. The comparison of environmental exposures
between Afro-Ecuadorians that continue to live in a rural
environment with those (of the same genetic 'stock') that
have migrated from the same rural environment to live in
an urban environment provides an important opportu-
nity to investigate how changes in environmental and life
style factors that follow urban migration may contribute
to changes in allergy risk.
Study population
The study will be conducted among school children
attending rural schools in Afro-Ecuadorian communities
in the District of Eloy Alfaro, in a tropical coastal area of
Esmeraldas Province, and in marginal Afro-Ecuadorian
'barrios' in an urban centre, where migrants from the rural
area (called norteños) congregate.
Study design
The study forms two parts: (i) a cross-sectional study of
environmental factors associated with atopy and allergic
symptoms in school-age children in the rural District of
Eloy Alfaro in Esmeraldas Province and in 'barrios' of the
city of Esmeraldas where rural migrants congregate; and
(ii) a nested case-control study of environmental risk fac-
tors for asthma using asthma cases identified from the
cross-sectional study in urban and rural school children
and a random sample of non-asthmatic controls.
1. Cross-sectional study
A total of 4,000 school children, aged 7 to 15 years, living
in the District of Eloy Alfaro and 2,500 children of the
same age range, living in the city of Esmeraldas, will be
assessed to estimate the frequency of atopy and allergic
diseases, including asthma, rhinitis and eczema, and iden-
tify and compare risk factors associated with these out-
comes in urban and rural study populations. School
children in urban areas will be defined by place of birth,
period of residence in urban area and at what age, and
whether their parents are migrants (i.e. born in a rural
area) or not. The cross-sectional study will examine the
relationship between atopy and allergic symptoms in
urban and rural school children and the environmental
factors that modify this relationship.
2. Nested case-control study
Asthma cases (200 cases in each of the urban and rural
areas) and non-asthmatic controls (800 controls in each
of the rural and urban areas), respectively, will be identi-
fied from the results of an allergy symptom questionnaire
performed in the cross-sectional study by the questions –
"Have you had wheezing or whistling in the chest in the
last 12 months? " and "Have you ever had wheezing or
whistling in the chest at any time in the past?" Non-asth-
matic controls will be randomly selected from all children
in each of the urban and rural areas that respond nega-
tively to the second question. Nested case-control studies
in the urban and rural areas will identify risk factors asso-
ciated with symptoms of recent wheeze using both quan-
titative and qualitative epidemiological methods,
investigations of immunological function and measure-
ments of allergens and endotoxin in the environment.
Sample size and study power
Data are available for the prevalence of recent wheeze in
urban and rural study areas, from pilot surveys of 245 and
536 school children, respectively. These surveys estimate
the prevalence of recent wheeze to be greater in the urban
area (urban 13.4% versus rural 7.3%). The prevalence of
atopy was similar in urban and rural school children
(urban 11.3% vs. rural 13.5%). A sample of 4,000 chil-
dren in the rural area and 2,500 children in the urban area
will provide approximately 820 cases of atopy for theBMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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cross-sectional study, and 292 and 335 cases of asthma for
the case-control study in the rural and urban areas, respec-
tively. Two hundred asthma cases from each area will be
recruited into case-control studies (allowing a drop-out
rate of ~ 30%). The study will have a case-control ratio of
1:4 (400 cases vs. 1,600 controls). With a study power of
80% and P < 0.05, the nested case-control studies com-
bined (i.e. urban and rural) will be able to detect signifi-
cant effects on asthma of common exposures (prevalences
of 40–60% – e.g. geohelminth infections and household
pets) with OR<0.7 and rare exposures (10%, e.g. family
history of allergic disease) with OR<0.5. Likewise, the
individual case-control studies (i.e. urban vs. rural) with
the same power and level of significance will be able to
detect an effect of OR<0.6 for common exposures (40–
60% prevalence), and OR<0.4 for rare exposures (10%).
Main exposures and definitions
Asthma, rhinitis and eczema will be defined according to
the core allergy symptom questions of the International
Study of Allergy and Asthma in Childhood (ISAAC) [22].
Atopy will be defined as a positive skin prick test to any of
the panel of aeroallergens tested. Allergy will be defined
by the presence of a history of appropriate symptoms of a
clinical allergic condition (asthma, rhinitis or eczema) in
the presence of atopy [23]. Information on important risk
factors and environmental exposures that affect the risk of
atopy and asthma will be collected as listed in Table 1.
Data collection and instruments
1. Questionnaires
A. Cross-sectional study: The questionnaire has been modi-
fied from the ISAAC Phase II study questionnaire [24],
and has been translated into Spanish and extensively field
tested [17,25]). The questionnaire includes the core
allergy symptoms questions of ISAAC and will collect
information on maternal and paternal educational level
and occupation; house construction; family possession of
material goods; family income; cooking materials; access
to water, electricity, and sanitation; household crowding;
exposures to pets and animals; exposures to farming,
including consumption of unpasteurized milk; dietary
questionnaire; physical activity and time spent watching
television; number of siblings and birth order; breast feed-
ing; day care attendance; family history of allergic disease;
exposure to smoking; detailed history of residence in
urban and rural areas of father and mother; and detailed
history of residence in urban and rural areas of child. The
questionnaire will be administered to the parent or guard-
ian of each child by trained field workers in the presence
of the child.
B. Case-control study: A questionnaire for a more detailed
history of asthma, rhinitis and eczema symptoms, based
on the ISAAC phase II supplementary questionnaires [24],
will be used. The questionnaire is designed to distinguish
between asthma and other common respiratory disorders.
The questionnaire includes also questions of the manage-
ment of asthma [24] and of risk factors for asthma. The
case-control study will include qualitative epidemiologi-
cal techniques to assess knowledge, attitudes, and practice
about asthma (KAP questionnaire). KAP questionnaires
will be administered to the parents of asthma cases and
non-asthmatic controls and also to health care personnel
in health centres in urban and rural areas. Deep interviews
with key informants in urban barrios and rural communi-
ties, focus groups and other qualitative epidemiological
techniques will be used to evaluate relevant lifestyle fac-
tors, and how different patterns between urban and rural
areas may contribute to risk (e.g. factors that are protective
in rural areas, such as rearing of livestock, may be risk fac-
tors in urban areas as recent migrants 'ruralise' their urban
environment).
2. Exercise test
The presence of exercise-induced bronchospasm (EIB)
will be assessed in all children in the case-control as
described previously [25,26]. Briefly, peak expiratory flow
rate (PEFR) is measured before and after 6 minutes of vig-
orous exercise and a fall of 15% in PEFR is considered to
indicate EIB.
2. Nutritional assessment
Finger prick blood samples will be collected from all sub-
jects in the cross-sectional study to estimate hemoglobin
level using standard procedures. Anthropometric meas-
urements will be performed using standardised method-
ology and will include weight (kg), height (cm) and
triceps skin fold thickness (mm). z-scores for weight-for-
age, weight-for-height and height-for-age will be calcu-
lated using the EPINUT program (Epi Info 6.0; CDC.
Atlanta, GA, USA).
3. Examination of stool samples for parasites
Single stool samples will be collected from all children
and examined using the modified Kato-Katz and formol-
ether concentration methods [27]. Intestinal helminth
parasite burdens (Kato-Katz) will be quantified as eggs per
gram of faeces. Infections with protozoan pathogens (for-
mol-ether concentration) will be graded as positive or
negative. All children with intestinal helminth infections
will be offered appropriate treatments with albendazole
and children with trophozoites of Entamoeba histolytica
(with ingested red cells) and Giardia intestinalis will be
offered appropriate doses of tinidazole.
4. Examination of dust samples
Dust samples will be collected from the homes of the chil-
dren in the case-control study using a ~ 1200 W vacuum
cleaner, weighed and stored as described previously [18].BMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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Table 1: Variables to be collected in the cross-sectional and nested case-control studies
Cross-sectional Case-control
Allergy questions
Core asthma symptom questions (ISAAC phase II) X X
Core rhinitis symptom questions (ISAAC phase II) X X
Core eczema symptom questions (ISAAC phase II) X X
Supplementary asthma questions (ISAAC phase II) X
Asthma management questions (ISAAC phase II) X
Rhinitis management questions (ISAAC phase II) X
Eczema management questions (ISAAC phase II) X
Knowledge attitude practice questions (KAP) X
Demographic and socio-economic
Sex XX
Age XX
Race XX
On socio-economic level:
parental schooling X
parental occupation XX
domestic goods XX
monthly income XX
Environmental factors
Sanitation and water supply XX
Does the house have electricity? X X
Pets
Has the child ever had a cat or dog living in the house? X
Does the child have a cat or dog living in the house currently? X X
Presence of animals outside household X X
Indoor smoking XX
Exposure to a farming environment X X
Housing (e.g. construction, number of rooms) X X
Presence of allergens in dust (mites and cockroach) X
Presence of endotoxin in the house X
Cooking materials XX
Maternal and family related factors
Maternal smoking during pregnancy X
Asthma and other allergic diseases in the family X
Breast-feeding duration X
Vaccination (BCG, DTP, measles) XBMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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Whether attended day care (and for what period) X
Number of people who live in each household X X
Number of siblings or children in the household X X
Birth order XX
Diet
Food frequency questionnaire XX
Consumption of unpasteurized milk X
Migration
Place of birth of child X
Place of birth of father X
Place of birth of mother X
Was the father brought up in an urban or rural area? X
Was the mother brought up in an urban or rural area? X
Period of time and places living outside place of birth during first 5 years of life X
Details of relatives living in the city of Esmeraldas X
Exercise/sedentarism
Number of hours of television watched daily X X
Frequency of vigorous exercise XX
Nutritional assessment
Hemoglobin XX
Height XX
Weight XX
Mid-upper arm circumference X
Triceps skin fold thickness X
Specific Infections
Intestinal helminth and protozoal infections (stool examinations) X X
A. lumbricoides IgE X
IgG for Toxoplasma. Gondii, Helicobacter pylori and viral infections X
Exercise test for exercise-induced bronchospasm X
Atopy
Skin prick test XX
Total and specific IgE titres to house dust mite and American cockroach X
Immunoregulatory cytokines
IL-10, IL-13, IFN-γ X
Table 1: Variables to be collected in the cross-sectional and nested case-control studies (Continued)BMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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Surveys of mites in dust samples and of cockroaches in
houses in the rural area show a predominance (>90%) of
both Dermatophagoides pteronyssinus mite and the Ameri-
can cockroach, Periplaneta americana. Dust samples will be
analyzed for endotoxin and fungal β-glucans (Limulus
lysate assay, BioWhittaker, MD, USA) and allergens from
D. pteronyssinus (Der p 1) and P. americana (Per a 1)
(Indoor Biotechnologies, VA, USA).
5. Examination of blood samples
Blood samples (7 mL) will be collected by venipuncture
from participants in the case-control study and will be
used for obtaining serum for the measurement of: poly-
clonal IgE [28]; IgE antibodies specific for D. pteronyssinus,
American cockroach, and Ascaris lumbricoides using the
Pharmacia CAP system (Phadia AB, Uppsala, Sweden);
IgG antibodies specific for hepatitis A virus, Helicobacter
pylori, herpes simplex virus, herpes zoster virus, Epstein-
Barr virus, and Toxoplasma gondii using commercially
available assays; and for whole blood cultures stimulated
with mitogen and relevant allergens for the measurement
of the regulatory cytokines, IFN-γ, IL-13, and IL-10, as
described elsewhere [18]. A whole blood pellet sample
will be stored at -40°C and shipped frozen to Imperial
College, London, UK, for genotyping of single nucleotide
polymorphisms using the Sequenom system (Sequenom
Inc, San Diego, CA, USA), as described previously [24].
6. Allergen skin prick testing
All children in the cross-sectional study will be tested for
immediate hypersensitivity responses to relevant aeroal-
lergens as described previously [25,28]. A positive test will
be taken as a wheal with a mean diameter of at least 3 mm
greater than the saline control 15 minutes after pricking
the allergen into the right forearm using an ALK Lancet
(ALK-Abello, Horsholm, Denmark). The following aller-
gens from Greer Laboratories Inc (Lenoir, NC, USA) will
be tested: D. pteronyssinus/D. farinae mix, American cock-
roach, Alternaria tenuis, cat, dog, '9 Southern grass mix',
and 'New stock fungi mix' .
Overview of statistical plan of analysis
The analysis will be designed to address five principal
study questions: 1) What is the frequency of atopy and
asthma in school children from the rural and urban study
areas? 2) What environmental exposures are associated
with atopy and asthma and how do these interact with
area of residence (rural vs. urban) to affect the relation-
ship between atopy and wheeze symptoms? 3) Do envi-
ronmental exposures associated with wheeze differ
between migrant and established urban populations and,
if so, are they potentially modifiable through intervention
programmes? 4) Are place of birth (rural vs. urban) and/
or period of residence in rural and urban areas associated
with risk of allergy? 5) How do complex inter-relation-
ships between factors at different levels (e.g. immunologic
factors and social factors) interact to affect the risk of
asthma in urban and rural populations? Statistical analy-
sis will be conducted according to a conceptual frame-
work that defines a proposed causal pathway and the
complex analytic approach to be used has been described
in detail in a companion paper [18]. Methods (epidemio-
logical and laboratory measurements) have been stand-
ardized between the Salvador-SCAALA [18] and this study
(Esmeraldas-SCAALA), a procedure that will permit com-
parisons between the two studies, and may allow the
identification of common risk/protective factors as well as
those that are peculiar to the different study sites.
Ethical considerations
Ethical approval for the study has been obtained from the
Hospital Pedro Vicente Maldonado, Provincia de Pichin-
cha, Ecuador. Written informed consent to participate in
the study will be obtained from the parent of each child
and signed minor assent will be obtained from each child.
The parent or guardian of each child will be provided with
a copy of all laboratory results and if, appropriate, treat-
ment recommendations will be made by a trained clini-
cian that will review each case.
Discussion
Atopic asthma and other allergic diseases are becoming
increasingly important public health problems in Latin
American cities and there is little published information
on the causes of this disease epidemic. The SCAALA
(Social Change, Asthma and Allergy in Latin America)
research initiative includes two epidemiological studies
being conducted in urbanizing populations (Esmeraldas
Province, Ecuador and the city of Salvador in Brazil,
respectively) that are investigating the environmental
causes of allergy in urban Latin America and the biological
and social mechanisms that underlie these epidemiologi-
cal trends. While the SCAALA-Salvador aims to investigate
the associations between the prevalence of asthma and
other allergic diseases (rhinitis, atopic eczema) and poten-
tial risk factors that includes living conditions and early
life and current exposures to infections [18], the SCAALA-
Esmeraldas study aims to study frequency of atopy and
allergic diseases and exposure to potential risk factor in
rural populations and in migrants from rural to urban
areas and examine how these may explain the risk of
atopic diseases in migrants from rural to urban areas. Both
studies will investigate how the association between envi-
ronment factors, allergic diseases and markers of atopy
(i.e. skin-prick test and total and specific serum IgE levels)
may be mediated by interleukins from antigen-stimulated
leukocytes.
The Esmeraldas-SCAALA study in Ecuador includes cross-
sectional and nested case-control studies conducted inBMC Pulmonary Medicine 2006, 6:24 http://www.biomedcentral.com/1471-2466/6/24
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rural and urban contexts. The studies are investigating the
impact of urban migration on asthma risk and the envi-
ronmental exposures that are associated with an increased
risk of asthma in populations that migrate from rural to
urban areas. The study will focus on a single ethnic cul-
tural group, Afro-Ecuadorians, that traditionally has lived
in the remote rural North Eastern region of Esmeraldas
Province, but that has migrated in significant numbers
over the past 30 years to cities such as the provincial capi-
tal, Esmeraldas. The study of a single and easily identifia-
ble group that presumably shares the same genetic 'stock'
and that has migrated locally (within the same Province)
should allow important environmental risk factors to be
identified more easily and should not suffer from the
biases that limit the interpretation of studies that have
investigated populations that have migrated between
countries. Specifically, the study, by investigating a
migrant population, will distinguish between the effects
of early life exposures (inducing immune programming)
and current exposures in determining allergy risk.
The knowledge generated from this study will help to
define the size of the public health problem of allergy in
Ecuador and may identify possible environmental expo-
sures that could be considered for primary prevention
public health strategies. The study in Brazil is a prospec-
tive study investigating the effects of early life exposures to
environmental factors, and the potential effects of these
on the immune system and the risk of allergy and has
been described in detail in a separate paper [18].
The causes of the allergy epidemic in Latin America are
assumed to be multifactorial and an important strength of
the SCAALA studies is the use of similar causal frame-
works and the sharing of methodology and expertise in a
wide range of scientific disciplines (e.g. epidemiology,
immunology, microbiology, biostatistics and social sci-
ences). The two studies are complementary and are likely
to yield important information on the underlying causes
of the allergy epidemic in urban Latin America.
In summary, the aim of the proposed programme is to
investigate the biological and social mechanisms that
underlie the epidemic of allergic diseases in urban Latin
America. Urbanization and the health problems associ-
ated with this phenomenon probably represent the single
most important challenge for health researchers working
in developing countries in the 21st century, and allergic
diseases are likely to emerge as the most prevalent of
chronic diseases of childhood in Latin America during this
century. Latin America urbanization has its roots on the
intense process of displacement of the poor rural popula-
tion that move to the urban centres looking for work and
other improvements in their life conditions. It is expected
that the knowledge generated from the SCAALA studies
will help identify public health interventions that may
ameliorate the adverse effects of urbanization on the prev-
alence and severity of asthma and allergic diseases.
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